Ligand validation:7CXA

TD2: 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-beta-D-galactopyranoside

TD2 is a Ligand Of Interest in 7CXA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CXA_TD2_A_302	51%	16%	0.126	0.878	2.34	1.4	17	9	0	0	100%	1
7CXA_TD2_B_302	48%	18%	0.122	0.865	2.01	1.57	15	13	0	0	100%	1
5E89_TD2_A_302	29%	11%	0.205	0.862	1.36	2.77	4	11	3	0	100%	0.7
7CXC_TD2_B_301	97%	18%	0.072	0.989	1.95	1.57	12	14	0	0	100%	0.5
7CXB_TD2_A_301	88%	22%	0.101	0.976	1.74	1.51	9	5	0	0	100%	0.5
7CXD_TD2_B_302	55%	23%	0.116	0.884	1.83	1.34	14	7	0	0	100%	1
4Y24_TD2_A_201	38%	12%	0.198	0.901	2.24	1.79	16	11	1	0	100%	1
5H9Q_TD2_B_201	33%	22%	0.162	0.841	1.84	1.44	14	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.